Home โ€บ Stocks โ€บ GLAND

Gland Pharma Ltd share price

GLAND ยท BSE
โ‚น3,097.50โ–ฒ 22.65 (0.74%)
Open
โ‚น3,074.95
Prev close
โ‚น3,074.85
Day high
โ‚น3,113.20
Day low
โ‚น3,048.45
52-wk high
โ‚น3,171.00
52-wk low
โ‚น1,574.00
See Gland Pharma Ltd live on Traddx Interactive charts, deep fundamentals, peer comparison & your own watchlist โ€” one of 4,800+ NSE & BSE stocks. Free to explore, no card needed.
Open live โ†’
๐Ÿ”” Get a free alert when Gland Pharma Ltd moves Set a price alert, save GLAND to your watchlist, and unlock the full AI deep dive. Free account โ€” 10 seconds with Google, no password.
Create free account โ†’

Gland Pharma Ltd (GLAND) is a stock listed on India's exchanges (NSE & BSE). As of the latest filings, Gland Pharma Ltd has a return on equity (ROE) of 10.70%, return on capital employed (ROCE) of 15.10%, a price-to-earnings (P/E) ratio of 44.60 and a debt-to-equity ratio of 0.03. On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal โ€” which star investors hold it and who is buying it on today's bulk/block deals tape.

Key fundamentals

ROE
10.70%
ROCE
15.10%
P/E
44.60
Book value
โ‚น629.00
Dividend yield
0.65%
Debt / equity
0.03
Market cap
โ‚น51,086.00 cr
Face value
โ‚น1.00

Source: screener.in (NSE/BSE filings) ยท Fundamentals as of 02 Nov 2026 ยท figures from the latest annual & quarterly filings. Not investment advice.

See GLAND live in the app โ†’

Gland Pharma Limited value chain โ€” customers, suppliers & competitors

Gland Pharma Limited is an injectable-focused pharmaceutical company operating primarily on a business-to-business (B2B) model, developing and manufacturing complex sterile injectables for global markets. It sits between raw material chemical suppliers and major global pharmaceutical marketing partners.

๐Ÿ›’ Customers โ€” who buys from Gland Pharma Limited

  • Global Pharmaceutical Marketing Partners โ€” Finished injectable formulations (B2B)

โ›“๏ธ Suppliers โ€” raw materials & inputs

โš”๏ธ Competitors โ€” other sellers

  • Emcure Pharmaceuticals Limited โ€” Competes in complex formulations and global markets; similar scale in portfolio breadth.
  • Lupin Limited โ€” Larger competitor with a broader global footprint across oral solids and injectables.
  • Piramal Pharma Limited โ€” Competes in contract development and manufacturing (CDMO) and sterile injectables.

๐Ÿ”€ Other suppliers to its customers

  • Other Global Injectable CDMOs โ€” Global pharmaceutical companies often dual-source sterile injectables from alternative manufacturers in Europe, China, or India.

๐Ÿค Peers that share its suppliers

This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.